Humacyte, Inc. short interest in 2022
In 2022, Humacyte, Inc.'s disclosed short interest ran from 2.87% of shares outstanding on 14 Jan 2022 to 4.42% on 30 Dec 2022, a change of +1.55 percentage points. The year's high was 8.67% on 15 Aug 2022 and its low 2.87% on 14 Jan 2022, averaging 5.84% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.54 days on 29 Jul 2022. Full history: Humacyte, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 2.87% (14 Jan 2022)
- End of year
- 4.42% (30 Dec 2022)
- Change
- +1.55 pp
- High
- 8.67% (15 Aug 2022)
- Low
- 2.87% (14 Jan 2022)
- Average
- 5.84%
- Highest days to cover
- 30.54 (29 Jul 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 2.87% | 5.04 | |
| 31 Jan 2022 | 3.37% | 6.77 | |
| 15 Feb 2022 | 3.86% | 11.24 | |
| 28 Feb 2022 | 3.88% | 15.53 | |
| 15 Mar 2022 | 4.28% | 14.29 | |
| 31 Mar 2022 | 4.77% | 10.74 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 5.50% | 17.81 | |
| 29 Apr 2022 | 5.71% | 21.43 | |
| 13 May 2022 | 6.05% | 15.24 | 10-Q filed, results (8-K) |
| 31 May 2022 | 7.33% | 13.39 | |
| 15 Jun 2022 | 7.17% | 14.64 | |
| 30 Jun 2022 | 7.29% | 11.62 | |
| 15 Jul 2022 | 8.02% | 24.92 | |
| 29 Jul 2022 | 8.46% | 30.54 | |
| 15 Aug 2022 | 8.67% | 14.28 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 8.17% | 29.07 | |
| 15 Sep 2022 | 7.63% | 15.93 | |
| 30 Sep 2022 | 7.79% | 25.49 | |
| 14 Oct 2022 | 6.41% | 15.90 | |
| 31 Oct 2022 | 5.53% | 22.02 | |
| 15 Nov 2022 | 4.46% | 12.92 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 4.27% | 14.73 | |
| 15 Dec 2022 | 4.35% | 12.50 | |
| 30 Dec 2022 | 4.42% | 6.22 |
See also: Humacyte, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.